Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.2535
-$0.0025-0.98%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -38.71% | -61.08% | -46.58% | -121.23% | -117.70% |
Total Depreciation and Amortization | -20.29% | -10.94% | 11.48% | 21.67% | 15.00% |
Total Amortization of Deferred Charges | -49.16% | -6.47% | 6.68% | 51.23% | 139.72% |
Total Other Non-Cash Items | 144.34% | 155.59% | 86.35% | 92.22% | -1,592.67% |
Change in Net Operating Assets | -37.02% | 1,702.30% | 232.97% | 45.76% | 144.64% |
Cash from Operations | -31.28% | -9.62% | -11.05% | -60.12% | -105.91% |
Capital Expenditure | -- | 100.00% | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 203.74% | 203.63% | 146.34% | 108.27% | -- |
Cash from Investing | 203.04% | 202.95% | 145.67% | 107.62% | -- |
Total Debt Issued | -73.57% | -93.65% | -100.00% | -100.00% | 504.73% |
Total Debt Repaid | 0.57% | -72.34% | -13.69% | 20.56% | -1,939.60% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 23.62% | 70.52% | 100.00% | 88.41% | -- |
Cash from Financing | 46.11% | -135.85% | -106.43% | -103.91% | -75.81% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 88.77% | 28.75% | -188.04% | -185.32% | -173.82% |